{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Palladium_Pd-103",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity.",
    "fdaUniiCode": "68QTV136DF",
    "identifier": "C2550",
    "preferredName": "Palladium Pd-103",
    "semanticType": "Element, Ion, or Isotope",
    "subclassOf": [
      "C799"
    ],
    "synonyms": [
      "PALLADIUM PD-103",
      "Palladium Pd 103",
      "Palladium Pd-103",
      "Palladium-103",
      "Pd 103",
      "radioactive palladium"
    ]
  }
}